Cervical cancer NEWS ▲ Last Updated: May 26, 2016 || Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)








Last Updated: May 26, 2016

• Involvement of myeloperoxidase gene polymorphism 463G>A in development of cervical squamous cell carcinoma.
  Roszak Andrzej, et al. The International journal of biological markers 2016 5 0
• Association of the Genetic Polymorphisms RRM1 -756T>C and -269C>A With Cervical Neoplasia.
  Chang Ching-Wen, et al. Biological research for nursing 2016 5
• Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
  Revathidevi Sundaramoorthy, et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 5
• Identification of genetic variants in TNF receptor 2 which are associated with the development of cervical carcinoma.
  Singhal Pallavi, et al. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2016 5 1-8
• Moonshot to Malawi.
  Gopal Satish et al. The New England journal of medicine 2016 Apr 374(17) 1604-1605
• Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
  Antonsson Annika, et al. Cancer causes & control : CCC 2016 4
• Association of DNA repair gene polymorphisms with response to cisplatin-based concurrent chemoradiotherapy in patients with cervical carcinoma.
  Liu Jin-Hui, et al. DNA repair 2016 4 69-72
• Lack of Associations between TNF-?Polymorphisms and Cervical Cancer in Thai women.
  Chinchai Teeraporn, et al. Asian Pacific journal of cancer prevention : APJCP 2016 0 (3) 953-6
• PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population.
  Wang Shizhi, et al. Scientific reports 2016 0 23465
• CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study.
  Santos Erinaldo Ubirajara Damasceno Dos, et al. Memorias do Instituto Oswaldo Cruz 2016 3
• Association between IL-27 2905T/G genotypes and the risk and survival of cervical cancer: a case-control study.
  Wang Guo-Qing, et al. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2016 2 1-4
• Epistatic Interaction of CYP1A1 and COMT Polymorphisms in Cervical Cancer.
  Matos Andreia, et al. Oxidative medicine and cellular longevity 2016 0 2769804
• Analysis of CYP1A1 and COMT polymorphisms in women with cervical cancer.
  Kleine J P, et al. Genetics and molecular research : GMR 2015 0 (4) 18965-73
• Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.
  Qureshi Rehana, et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 1
• Reach of the Montana Cancer Control Program to Women with Disabilities.
  Disease: Breast Cancer|Ovarian Cancer; Type: Data|Program; State: Montana
• Eileen’s Cancer Survivor Story
  I had a family history of cervical and uterine cancers but I didn?t get checked until I had symptoms.
• Targeted Cancer Screening in Average-Risk Individuals.
  Marcus Pamela M et al. American journal of preventive medicine 2015 Nov 49(5) 765-71
• Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer.
  Bhat Samatha, Kabekkodu Shama Prasada, Noronha Ashish, Satyamoorthy Kapaettu.Biochimie 2015 Dec
• Cervical Cancer Awareness 
• Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
  Liu Ying et al. Oncotarget 2015 Dec
• A Suggested Approach to Simplify and Improve Cervical Screening in the United States.
  Schiffman Mark et al. Journal of lower genital tract disease 2016 Jan (1) 1-7
• Genetic diversity of HPV16 and HPV18 in Brazilian patients with invasive cervical cancer.
  Vidal Joao Paulo C B et al. Journal of medical virology 2015 Dec
• Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer.
  Bodelon Clara et al. Carcinogenesis 2015 Dec
• Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection.
  Cullen Michael et al. Papillomavirus research 2015 Dec 3-11
• Hsa-miR-449a genetic variant is associated with risk of gastric cancer in a Chinese population.
  Shi Jian, et al. International journal of clinical and experimental pathology 2015 0 (10) 13387-92
• Relationship between hWAPL polymorphisms and cervical cancer susceptibility.
  Li Li, et al. International journal of clinical and experimental pathology 2015 0 (10) 13777-82
• Protect Your Daughters from Cervical Cancer 
• MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).
  González-Quintana Víctor et al. Oncology reports 2016 Jan (1) 3-12
• Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.
  Horikawa Naoki et al. BMC cancer 2015 739
• HER2 as a novel therapeutic target for cervical cancer.
  Oh Doo-Yi et al. Oncotarget 2015 Nov (34) 36219-30

• CDC Information (6)
• CDC-Authored Pub (3)

• Human (0)
• Pathogen (7)

• Human (669)
• Pathogen (0)

• Human (3)
• Pathogen (1)

• Guidelines (0)
• Tier Table (0)
• Synthesis (3)

• Implementation (20)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB